TerminatedPhase 4NCT00742157

Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)

Studying Short bowel syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Nebraska
Principal Investigator
Fedja Rochling, MB, ChB
University of Nebraska
Intervention
Growth Hormone(drug)
Enrollment
5 enrolled
Eligibility
19-78 years · All sexes
Timeline
20032008

Study locations (1)

Collaborators

Eli Lilly and Company

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00742157 on ClinicalTrials.gov

Other trials for Short bowel syndrome

Additional recruiting or active studies for the same condition.

See all trials for Short bowel syndrome

← Back to all trials